News - page 38 - Healixia

June 2, 2020

Coronavirus: reminder of the risks of chloroquine and hydroxychloroquine

Heard from FAMHP

The FAMHP restates the risks linked to the use of chloroquine and hydroxychloroquine to treat COVID-19 following the publication of a retrospective analysis of a patient monitoring register in the medical journal The Lancet on 22 May 2020. The analysis did not highlight any benefits from these drugs in patients with COVID-19 and revealed adverse cardiovascular effects.

June 2, 2020

Coronavirus: updated guidelines for verifying the compliance and suitability of surgical face masks

Heard from FAMHP

The FAMHP has issued guidelines for checking the compliance and suitability of surgical face masks during the COVID-19 crisis. The guidelines are intended for companies, institutions and authorities that order, sell or use these masks.

June 2, 2020

Coronavirus: recommendations for replacing closed suction systems

Heard from FAMHP

The FAMHP reminds hospitals of the recommendations for replacing closed suction systems and offers temporary practical advice to help healthcare professionals waiting on a new stock of suction systems.

June 2, 2020

Coronavirus: relaxation of paracetamol measures for pharmacists and patients

Heard from FAMHP

Sales of paracetamol remain stable, which is why the restriction of only one box per patient is being lifted. The quotas for pharmaceutical companies and wholesalers have already been abolished. Only the intravenous form remains subject to restriction.

June 2, 2020

The FAMHP web portal - updates to the “My company” and “My activities” applications

Heard from FAMHP

In anticipation of the European regulations on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), the FAMHP has updated the “My company” and “My activities” applications in its web portal.

June 2, 2020

Coronavirus: extension and relaxation of measures taken by the FAMHP to prevent shortages of medicines

Heard from FAMHP

Coronavirus: verlenging en versoepeling van maatregelen die het FAGG heeft genomen om tekorten aan geneesmiddelen te vermijden

Coronavirus : extension et assouplissement des mesures prises par l'AFMPS pour éviter la pénurie de médicaments

May 14, 2020

Coronavirus: update of guidelines to check the conformity and suitability of surgical mouth masks

Heard from FAMHP

Coronavirus: update van de richtlijnen om de conformiteit en geschiktheid van chirurgische mondmaskers na te gaan

Coronavirus : mise à jour des lignes directrices pour vérifier la conformité et l’aptitude des masques buccaux chirurgicaux

May 7, 2020

Pharmaboardroom.com had a talk with Healixia President Erik Present

PharmaBoardroom, a leading website for C-Level executives working in Healthcare and Life Sciences interviewed Healixia President Erik Present.

May 6, 2020

Coronavirus: national guideline for the management of clinical investigation for medical devices during the coronavirus pandemic

Heard from FAMHP

Coronavirus: nationale richtlijn voor het beheer van klinische onderzoek voor medische hulpmiddelen tijdens de coronaviruspandemie

Coronavirus : ligne directrice nationale pour la gestion d’investigations cliniques sur les dispositifs médicaux durant la pandémie de coronavirus

May 6, 2020

Coronavirus: European Medicines Agency advises continued use of medicines to treat high blood pressure, heart and kidney disease

Heard from FAMHP

Coronavirus: Europees Geneesmiddelenbureau adviseert om geneesmiddelen tegen hoge bloeddruk, hart- en nieraandoeningen te blijven gebruiken

Coronavirus : l’Agence européenne des médicaments recommande de continuer à utiliser les médicaments contre l’hypertension, les maladies cardiaques ou rénales